Based in East and West Cheshire the AAT provides services for assessment and diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) and ADHD treatment and medication monitoring, if required, in East Cheshire, and assessment and diagnosis of Autism in East and West Cheshire. This does not include children and young people who access health services from Winsford, Northwich, Bunbury, Frodsham or Helsby practices (unless they live in Elton). The Team is not commissioned to offer post-diagnostic support for Autism , however will signpost to resources and services available in the local area.

Assessment and monitoring clinics are held at various locations in the local area, with main bases at Elm House and Space4Autism in East Cheshire and Marsden House in West Cheshire. 

16-17 year old young people : ( Cheshire East & Cheshire West & Chester) 

The Adult ADHD service is currently closed to referrals with the exception of the below:

  1. 16–17-year-old Cheshire GP patients
  2. Cheshire GP patients with an established ADHD diagnosis who are receiving ADHD medication without specialist support.
  3. Transitions from paediatric services

Enquires to:  cwp.adultadhd@nhs.net /  0300 3033157

Referrals to : cwp.adhdreferrals@nhs.net

If patient does not meet above criteria, you may wish to refer to interim ADHD service via Right to Choose: https://adhduk.co.uk/right-to-choose/ ) as an alternative to waiting until we reopen to new referrals.

ADHD diagnostic assessment

The ADHD Team provides assessment to children and young people aged 6-16 years who have a GP in Cheshire East. The team accepts referrals for children and young people who have not received a previous diagnosis of ADHD.

ADHD treatment and medication monitoring

This service is available to children and young people aged 6-16 years who have received a diagnosis of ADHD and have a GP in Cheshire East.

Autism diagnostic assessment

The Autism Team provides assessment to children and young people aged 4-16 years and who have a GP in Cheshire East, and to children and young people aged 11-16 years and who have a GP in Cheshire West. This does not include children and young people who access health services from Winsford, Northwich, Bunbury, Frodsham or Helsby practices (unless they live in Elton). The Team accepts referrals for children and young people who have not received a previous diagnosis of Autism.

 

16-17 year olds - cheshire:

The Adult ADHD service is currently closed to referrals with the exception of the below:

  1. 16–17-year-old Cheshire GP patients
  2. Cheshire GP patients with an established ADHD diagnosis who are receiving ADHD medication without specialist support.
  3. Transitions from paediatric services

Enquires to:  cwp.adultadhd@nhs.net /  0300 3033157

Referrals to : cwp.adhdreferrals@nhs.net

If patient does not meet above criteria, you may wish to refer to interim ADHD service via Right to Choose: https://adhduk.co.uk/right-to-choose/ ) as an alternative to waiting until we reopen to new referrals.

ADHD and Autism Assessment Service Providers

 

For Cheshire West please refer via the Community Paediatric Service

For Cheshire East referrals are made online via the online referral form on this page. 

ADHD areas covered

  • East Cheshire – age 6-16 years
    • Poynton
    • Wilmslow
    • Macclesfield
    • Knutsford
    • Congleton
    • Holmes Chapel

Details of other providers for ADHD

ASC areas covered

  • East Cheshire – age 4-18 years
    • Poynton
    • Wilmslow
    • Macclesfield
    • Knutsford
    • Congleton
    • Holmes Chapel

Details of other providers for ASC

  • West Cheshire – age 0-16 years 

Submit an online referral to our CYP ADHD and Autism Service

SEND Partnership briefing on ADHD and ASC (North) East Cheshire

SEND partnership .jpg

 

East Cheshire  ADHD  transition process to adult services

AAT to Adult pathway flow chart (1) (1).jpg

 

There are supply disruptions affecting various strengths of the following medications which are licensed for the treatment of attention deficit hyperactivity disorder (ADHD): 

• Methylphenidate:* 

Equasym XL® 10, 20 and 30 mg capsules 

Xaggitin XL® 18 and 36 mg prolonged-release tablets 

Concerta XL® 54 mg prolonged-release tablets 

Xenidate XL® 27 mg prolonged-release tablets 

• Lisdexamfetamine: 

Elvanse® 20, 30, 40, 50, 60 and 70 mg capsules 

Elvanse® Adult 30, 50, and 70 mg capsules 

• Guanfacine: 

Intuniv® 1, 2, 3 and 4 mg prolonged-release tablets 

At present, the supply disruptions are expected to resolve at various dates between October and December 2023 

• Atomoxetine: 

The Department of Health and Social Care (DHSC) issued a Medicine Supply Notification in August 2023 for the shortage of atomoxetine capsules. The supply issue with atomoxetine is set to resolve in October 2023. 

The supply disruption of these products is caused by a combination of manufacturing issues and an increased global demand. 

The following medications, also commonly used to treat ADHD, continue to be in good supply.

Methylphenidate immediate release tablet:

  • Tranquilyn
  • Ritalin
  • Medikinet


Methylphenidate (8-hour release):

  • Medikinet XL prolonged release capsules


Methylphenidate prolonged release tablets (12-hour release):

  • Matoride XL
  • Delmosart XL
  • Affenid XL (these can be used as a direct replacement for affected strengths of Concerta Xl, Xenidate XL, Xaggitin XL)